InMed Pharmaceuticals SG&A Expense (Quarterly) Analysis

InMed Pharmaceuticals Inc (INM)

0.301 0.00 (0.00%) USD | NASDAQ | Apr 18, 16:00

0.301 0.00 (0.00%) After-Hours: 19:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2001. Upgrade now.

Date	Value
December 31, 2023	1.364M
September 30, 2023	1.299M
June 30, 2023	1.409M
March 31, 2023	1.413M
December 31, 2022	1.465M
September 30, 2022	1.560M
June 30, 2022	1.742M
March 31, 2022	1.915M
December 31, 2021	1.837M
September 30, 2021	1.373M
June 30, 2021	1.561M
March 31, 2021	1.334M
December 31, 2020	0.9596M
September 30, 2020	0.6248M
June 30, 2020	0.5656M
March 31, 2020	0.9023M
December 31, 2019	0.8717M
September 30, 2019	0.8875M
June 30, 2019	1.464M
March 31, 2019	1.407M
December 31, 2018	1.428M
September 30, 2018	1.731M
June 30, 2018	1.829M
March 31, 2018	1.218M
December 31, 2017	0.8733M

Date	Value
September 30, 2017	1.138M
June 30, 2017	1.173M
March 31, 2017	0.7764M
December 31, 2016	0.5565M
September 30, 2016	0.2848M
June 30, 2016	0.3342M
March 31, 2016	0.2433M
December 31, 2015	0.4217M
September 30, 2015	0.4339M
June 30, 2015	0.9183M
March 31, 2015	0.8791M
December 31, 2014	0.4049M
September 30, 2014	0.5141M
June 30, 2014	0.9841M
March 31, 2014	0.0787M
December 31, 2013	0.0221M
September 30, 2013	0.011M
June 30, 2013	0.0228M
March 31, 2013	0.0076M
December 31, 2012	-0.006M
September 30, 2012	0.0229M
June 30, 2012	0.0596M
March 31, 2012	0.0227M
December 31, 2011	0.0263M
September 30, 2011	0.0408M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.5656M

Minimum

Jun 2020

1.915M

Maximum

Mar 2022

1.292M

Average

1.373M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks